PKD2 Antikörper (Internal Region)
Kurzübersicht für PKD2 Antikörper (Internal Region) (ABIN571031)
Target
Alle PKD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- Polycystin 2 / PKD2
-
Sequenz
- ERAKLKRREV LGR
-
Kreuzreaktivität
- Rind (Kuh), Human, Maus, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- C-ERAKLKRREVLGR
-
Isotyp
- IgG
-
-
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 261-360) antibody
PKD2 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 4C8 unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 621-832) antibodyPKD2 Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 327-539) antibodyPKD2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 914-927), (C-Term), (Intracellular) antibodyPKD2 Reaktivität: Human WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 261-360) antibodyPKD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1G3 unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 680-968) antibodyPKD2 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 240-410) antibodyPKD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (C-Term) antibodyPKD2 Reaktivität: Human WB, IP, IHC (fp) Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) (AA 918-968) antibodyPKD2 Reaktivität: Human, Maus WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2) antibodyPKD2 Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 25GB655 unconjugated
-
-
Applikationshinweise
-
Western Blot: Approx 100 kDa band observed in lysates of cell line HeLa (calculated MW of 110 kDa according to NP_000288.1). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:2000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))
-
Andere Bezeichnung
- PKD2
-
Hintergrund
- PKD2, polycystic kidney disease 2 (autosomal dominant), APKD2, MGC138466, MGC138468, PC2, PKD4, polycystin 2, polycystwin
-
Gen-ID
- 5311, 18764, 498328
-
NCBI Accession
- NP_000288
-
Pathways
- cAMP Metabolic Process, Maintenance of Protein Location, Negative Regulation of Transporter Activity
Target
-
